Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1948 1
1950 2
1951 1
1952 2
1953 3
1954 3
1956 1
1957 1
1958 1
1961 4
1962 3
1963 21
1964 19
1965 28
1966 19
1967 19
1968 49
1969 42
1970 38
1971 33
1972 23
1973 31
1974 25
1975 33
1976 36
1977 48
1978 50
1979 52
1980 67
1981 79
1982 89
1983 94
1984 108
1985 91
1986 101
1987 97
1988 125
1989 162
1990 126
1991 148
1992 178
1993 183
1994 184
1995 213
1996 203
1997 212
1998 234
1999 275
2000 284
2001 285
2002 307
2003 332
2004 329
2005 383
2006 381
2007 436
2008 395
2009 416
2010 449
2011 477
2012 542
2013 594
2014 553
2015 600
2016 591
2017 668
2018 683
2019 688
2020 800
2021 830
2022 837
2023 778
2024 579
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

15,186 results

Results by year

Filters applied: . Clear all
Page 1
JAK inhibitors for rheumatoid arthritis.
Kubo S, Nakayamada S, Tanaka Y. Kubo S, et al. Among authors: tanaka y. Expert Opin Investig Drugs. 2023 Apr;32(4):333-344. doi: 10.1080/13543784.2023.2199919. Epub 2023 Apr 7. Expert Opin Investig Drugs. 2023. PMID: 37014106 Review.
Systemic lupus erythematosus.
Tanaka Y. Tanaka Y. Best Pract Res Clin Rheumatol. 2022 Dec;36(4):101814. doi: 10.1016/j.berh.2022.101814. Epub 2023 Jan 24. Best Pract Res Clin Rheumatol. 2022. PMID: 36702700 Review.
Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant.
Uriu K, Ito J, Kosugi Y, Tanaka YL, Mugita Y, Guo Z, Hinay AA Jr, Putri O, Kim Y, Shimizu R, Begum MM, Jonathan M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Ikeda T, Sato K. Uriu K, et al. Among authors: tanaka yl. Lancet Infect Dis. 2023 Nov;23(11):e460-e461. doi: 10.1016/S1473-3099(23)00575-3. Epub 2023 Sep 18. Lancet Infect Dis. 2023. PMID: 37734391 No abstract available.
Generation of ventralized human thalamic organoids with thalamic reticular nucleus.
Kiral FR, Cakir B, Tanaka Y, Kim J, Yang WS, Wehbe F, Kang YJ, Zhong M, Sancer G, Lee SH, Xiang Y, Park IH. Kiral FR, et al. Among authors: tanaka y. Cell Stem Cell. 2023 May 4;30(5):677-688.e5. doi: 10.1016/j.stem.2023.03.007. Epub 2023 Apr 4. Cell Stem Cell. 2023. PMID: 37019105 Free PMC article.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II).
Petri M, Bruce IN, Dörner T, Tanaka Y, Morand EF, Kalunian KC, Cardiel MH, Silk ME, Dickson CL, Meszaros G, Zhang L, Jia B, Zhao Y, McVeigh CJ, Mosca M. Petri M, et al. Among authors: tanaka y. Lancet. 2023 Mar 25;401(10381):1011-1019. doi: 10.1016/S0140-6736(22)02546-6. Epub 2023 Feb 24. Lancet. 2023. PMID: 36848919 Clinical Trial.
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial.
Krop IE, Masuda N, Mukohara T, Takahashi S, Nakayama T, Inoue K, Iwata H, Yamamoto Y, Alvarez RH, Toyama T, Takahashi M, Osaki A, Saji S, Sagara Y, O'Shaughnessy J, Ohwada S, Koyama K, Inoue T, Li L, Patel P, Mostillo J, Tanaka Y, Sternberg DW, Sellami D, Yonemori K. Krop IE, et al. Among authors: tanaka y. J Clin Oncol. 2023 Dec 20;41(36):5550-5560. doi: 10.1200/JCO.23.00882. Epub 2023 Oct 6. J Clin Oncol. 2023. PMID: 37801674 Free PMC article. Clinical Trial.
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment.
Yabushita T, Chinen T, Nishiyama A, Asada S, Shimura R, Isobe T, Yamamoto K, Sato N, Enomoto Y, Tanaka Y, Fukuyama T, Satoh H, Kato K, Saitoh K, Ishikawa T, Soga T, Nannya Y, Fukagawa T, Nakanishi M, Kitagawa D, Kitamura T, Goyama S. Yabushita T, et al. Among authors: tanaka y. Cell Rep. 2023 Sep 26;42(9):113098. doi: 10.1016/j.celrep.2023.113098. Epub 2023 Sep 14. Cell Rep. 2023. PMID: 37714156 Free article.
15,186 results
You have reached the last available page of results. Please see the User Guide for more information.